New Delhi, Dec. 15 -- Corona Remedies share price made a robust debut in the Indian stock market today, December 15. Corona Remedies share price was listed at Rs.1,461 apiece on NSE, a premium of 37.57% over its issue price of Rs.1,062. Meanwhile, on BSE, it listed at Rs.1,452, up 36.72%.

Corona Remedies IPO outperformed Street expectations, as seen from the grey market premium (GMP). The GMP for Corona Remedies IPO stood at Rs.342.50 per share, which indicated a likely listing price of around Rs.1,404.50- translating to a premium of 32.25% over the upper end of the issue price band.

Corona Remedies IPO witnessed exceptional subscription in the three days of bidding. It was subscribed a whopping 144.54 times by the end of the third day....